Correlation Between GlucoTrack and ReShape Lifesciences
Can any of the company-specific risk be diversified away by investing in both GlucoTrack and ReShape Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlucoTrack and ReShape Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlucoTrack and ReShape Lifesciences, you can compare the effects of market volatilities on GlucoTrack and ReShape Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlucoTrack with a short position of ReShape Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlucoTrack and ReShape Lifesciences.
Diversification Opportunities for GlucoTrack and ReShape Lifesciences
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between GlucoTrack and ReShape is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding GlucoTrack and ReShape Lifesciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ReShape Lifesciences and GlucoTrack is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlucoTrack are associated (or correlated) with ReShape Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ReShape Lifesciences has no effect on the direction of GlucoTrack i.e., GlucoTrack and ReShape Lifesciences go up and down completely randomly.
Pair Corralation between GlucoTrack and ReShape Lifesciences
Given the investment horizon of 90 days GlucoTrack is expected to under-perform the ReShape Lifesciences. But the stock apears to be less risky and, when comparing its historical volatility, GlucoTrack is 1.9 times less risky than ReShape Lifesciences. The stock trades about -0.91 of its potential returns per unit of risk. The ReShape Lifesciences is currently generating about -0.26 of returns per unit of risk over similar time horizon. If you would invest 365.00 in ReShape Lifesciences on November 29, 2024 and sell it today you would lose (249.00) from holding ReShape Lifesciences or give up 68.22% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlucoTrack vs. ReShape Lifesciences
Performance |
| Timeline |
| GlucoTrack |
| ReShape Lifesciences |
GlucoTrack and ReShape Lifesciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlucoTrack and ReShape Lifesciences
The main advantage of trading using opposite GlucoTrack and ReShape Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlucoTrack position performs unexpectedly, ReShape Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ReShape Lifesciences will offset losses from the drop in ReShape Lifesciences' long position.| GlucoTrack vs. Nexgel Inc | GlucoTrack vs. Sharps Technology | GlucoTrack vs. Innovative Eyewear | GlucoTrack vs. Predictive Oncology |
| ReShape Lifesciences vs. SINTX Technologies | ReShape Lifesciences vs. Bone Biologics Corp | ReShape Lifesciences vs. Tivic Health Systems | ReShape Lifesciences vs. Nuwellis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |